SNMMI

Cardiac positron emission tomography (PET) perfusion images for two representative patients. Both patients had similar demographic characteristics. Neither patient had significant perfusion abnormalities as shown in the figure. Patient A had mild sleep apnea while patient B had severe obstructive sleep apnea. The corrected myocardial flow reserve (MFR) for patient A was normal at 3.24 while for patient B it was severely abnormal at 1.22.

PET Imaging Confirms Link Between Obstructive Sleep Apnea and Heart Blood Flow Impairment

June 15, 2022 — Patients with severe obstructive sleep apnea (OSA) are less able to increase blood flow to the heart ...

June 15, 2022

News | SNMMI

SNMMI Names Helen Nadel, MD, FRCPC, as President-Elect at 2022 Annual Meeting

June 15, 2022 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

June 15, 2022

Heat maps of PSMA PET prostatic fossa recurrence in patients with recurrence limited to the prostate fossa (miTr N0 M0, n=127), pelvic nodal disease (miTr N1 M0, n=30), distant organs/extra-pelvic nodal disease (miTr N0 M1, n=32) and pelvic nodal plus distant organs/extra-pelvic nodal disease (miTr N1 M1, n=37). The yellow contour represents the RTOG CTV

News | Prostate Cancer

PSMA PET Highlights Need for Updated Prostate Cancer Therapy Guidelines

June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of ...

June 15, 2022

Representative axial image from a test set imaging study. From top left to bottom right: CT (A), NAC-PET (B), original AC-PET (C), AI-generated AC-PET (D). The blue arrow indicates one lesion that was observed in both images, and the red arrow indicates a lesion that was missed (i.e., not de-tected by expert nuclear medicine physicians) in AI image. NAC = Non-Attenuation Corrected. AC = Attenuation-Corrected

News | PET-CT

Virtual CT Scans Cut Patient Radiation Exposure in Half During PET/CT Studies

June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...

June 14, 2022

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.

News | SNMMI

SNMMI Launches Mars Shot Fund for Nuclear Medicine Research

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot ...

June 14, 2022

News | SNMMI

SNMMI elects Munir Ghesani, MD, FACNM, FACR, as President at 2022 Annual Meeting

June 14, 2022 — Munir Ghesani, MD, FACNM, FACR, chief of nuclear medicine and molecular imaging at Mount Sinai Health ...

June 14, 2022

Offers enhanced SPECT and CT imaging functionalities, including 64-slice CT and automated SPECT motion correction, as well as automated workflow

News | SPECT-CT

Siemens Healthineers Announces FDA Clearance of Symbia Pro.specta SPECT/CT Scanner

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro ...

June 13, 2022

SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences industry that specializes in radiopharmaceuticals, today announced that it will showcase its new Actinium-225 production facility during this year’s annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting being held June 11-14 in Vancouver, British Columbia, Canada.

News | Radiopharmaceuticals and Tracers

SpectronRx to Showcase New Facility for the Global Supply of Actinium-225 at SNMMI 2022

June 13, 2022 — SpectronRx, a leading contract development and manufacturing organization (CDMO) for the life sciences ...

June 13, 2022

At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer

News | Prostate Cancer

GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health and Theranostics for Personalized Prostate Cancer Care

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

June 10, 2022

New Information Statement Addresses How Labs Should Manage Evolving Issues as Pandemic Shifts Toward Chronic Endemic State

News | Coronavirus (COVID-19)

ASNC, IAEA, SNMMI Update COVID-19 Best Practices for Nuclear Cardiology Labs

May 4, 2022 — While the COVID-19 pandemic transitions through various phases, nuclear cardiology teams should maintain a ...

May 04, 2022

News | Nuclear Imaging

New ASNC/SNMMI Training Course Helps Physicians Meet U.S. Requirements for Handling Medical Radioisotopes

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

April 13, 2022

Quantitative analysis of pre-treatment PSMA PET/CT in a patient undergoing treatment with ¹⁷⁷Lutetium-PSMA-617/NOX66. Post-treatment PSMA PET/CT demonstrates reduced tumor volume and PSMA intensity. Images created by S Pathmanandavel and L Emmett, St Vincent's Hospital, Sydney, Australia.

News | PET-CT

New Radionuclide Combination Therapy Safe and Effective in Metastatic Prostate Cancer Patients

April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre ...

April 11, 2022

Serial non-contrast axial chest CTs of three study participants with prior COVID-19 pneumonia.

Feature | Radiology Business | By Melinda Taschetta-Millane

Top 10: Most Read Radiology Technology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

March 31, 2022

With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.

News | Prostate Cancer

SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

March 23, 2022

F-18 FDG PET in COVID-19–related CNS disorders: Principal components analysis of spatial covariance pattern (first row) and statistical parametric mapping analysis of metabolic group differences (second to fifth rows) in patients with COVID-19–related encephalopathy, patients with post-COVID-19 syndrome, and patients with post-COVID-19 syndrome and hyposmia compared to healthy controls (n=13). Image Created by PT Meyer, S Hellwig, G Blazhenets and JA Hosp, Medical Center – University of Freiburg, Germany.

News | Coronavirus (COVID-19)

Molecular Imaging Uncovers Effects of COVID-19 on the Brain

March 23, 2022 — A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive ...

March 23, 2022

Dose tracking software allows hospitals and imaging centers to track levels of radiation used by exam type protocol.

Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Measuring Radiation Dose

Dose tracking software allows hospitals and imaging centers to track levels of radiation used by exam type protocol. It ...

March 22, 2022

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence.

News | SNMMI

SNMMI designates first Radiopharmaceutical Therapy Centers of Excellence

March 16, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the ...

March 16, 2022

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

News | Nuclear Imaging

Position Statement from SNMMI Regarding Situation in Ukraine

March 3, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine ...

March 03, 2022

The Task Force members have recently observed an unusual imaging pattern on FDG PET/CT or FDG PET/MR that may be due to COVID-19 infection.

News | Coronavirus (COVID-19)

SNMMI Task Force Reports Possible Effect of Omicron Infection on FDG PET/CT Scans

January 17, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) issued a statement on Jan. 14 regarding ...

January 17, 2022

Case examples of quantitative plaque analysis on coronary CT angiography and 18F-NaF PET in patients with established coronary artery disease. Hybrid CT angiography and 18F-NaF PET of coronary arteries. (A) A 70-y-old male, who presented with diffused largely noncalcified disease (middle panel in red) in the LAD and demonstrated increased 18F-NaF uptake in the LAD on PET. (B) A 59-y-old male with mild LCX atherosclerosis, who presented with a high noncalcified plaque burden (middle panel in red) on CT angio

News | PET-CT

PET/CT Artificial Intelligence Model Ideal for Predicting Risk of Future Heart Attack

January 12, 2022 — By combining information from two advanced imaging techniques with clinical data, physicians can ...

January 12, 2022